DX

Daigen Xu

Merck: 3 patents #3,073 of 9,382Top 35%
RA Roche Glycart Ag: 2 patents #32 of 86Top 40%
AT Aegera Therapeutics: 1 patents #22 of 30Top 75%
TO The University Of Ottawa: 1 patents #117 of 325Top 40%
Overall (All Time): #696,963 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12054549 Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders Ilhan Celik, Eike Staub, Miriam Urban, Sabine Raab-Westphal, Eileen Samy +3 more 2024-08-06
11485786 Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders Ilhan Celik, Eike Staub, Miriam Urban, Sabine Raab, Eileen Samy +3 more 2022-11-01
10040843 Interleukin-10 fusion proteins and uses thereof Lydia Jasmin Duerner, Thomas Emrich, Jens Fischer, Ralf Hosse, Ekkehard Moessner +1 more 2018-08-07
10012650 Assays for BTK inhibitors Andrew Bender, Lesley Liu-Bujalski, Albertina Pereira, Richard D. Caldwell, Roland Grenningloh 2018-07-03
9346872 Interleukin-10 fusion proteins Lydia Jasmin Duerner, Thomas Emrich, Jens Fischer, Ralf Hosse, Ekkehard Moessner +1 more 2016-05-24
6709866 Methods for enhancing survival of a neuron George Robertson, Robert G. Korneluk, Alexander E. MacKenzie, Stephen J. Crocker 2004-03-23
6159948 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease George Robertson, Robert G. Korneluk, Alexander E. MacKenzie, Stephen J. Crocker 2000-12-12